Research Article
Regression of Left Ventricular Hypertrophy in Patients Combined with Peritoneal Dialysis and Hemodialysis
Table 2
Comparison of clinical and laboratory parameters before and after PHD.
| | Before PHD | After PHD | |
| Body weight (kg) | 61.1 ± 9.0 | 59.3 ± 8.6 | 0.453 | SBP (mmHg) | 141.7 ± 21.8 | 135.5 ± 15.6 | 0.002 | DBP (mmHg) | 85.7 ± 7.9 | 82.7 ± 8.3 | 0.002 | Ultrafiltration volume (mL/d) | 1012 ± 553 | 1233 ± 531 | 0.021 | PD | 1012 ± 553 | 668 ± 222 | | HD | 0 | 470 ± 150 | | iPTH (pg/ml) | 244 (126, 381) | 225 (114, 354) | 0.47 | Hb (g/L) | 96.0 ± 18.4 | 103.3 ± 14.0 | 0.001 | ALB (g/L) | 36.1 ± 5.2 | 36.4 ± 4.8 | 0.38 | Ca (mmol/L) | 2.32 ± 0.16 | 2.29 ± 0.16 | 0.20 | P (mmol/L), | 1.96 ± 0.54 | 1.84 ± 0.49 | <0.001 | BUN (mmol/L) | 19.2 ± 5.5 | 18.7 ± 4.8 | 0.24 | Scr (umol/L) | 1209.6 ± 259.4 | 1227.8 ± 247.3 | 0.54 | ESA dosage (104 u/W) | 4.3 ± 0.4 | 3.5 ± 0.3 | <0.001 |
|
|
SBP, systolic blood pressure; DBP, diastolic blood pressure; iPTH, intact parathyroid hormone; Hb, hemoglobin; ALB, albumin; Ca, calcium; P, phosphorus; BUN, urea nitrogen; Scr, serum creatinine; ESA, erythropoietin stimulating agents.
|